Stromal cell-derived factor-1α as a novel biomarker for hyperlipidemia

Tohoku Journal of Experimental Medicine

Volumn 228, Issue 4, 2012, Pages 355-363

  Li, Shou Lin ^a,b   Lin, Wei ^a,b   Zhang, Yan ^a,b   Zheng, Zhi Chang ^a,b   Liu, Li Jun ^a,b   Fu, Hao ^a,b   Liu, Jie ^a,b   Wang, Guo Dong ^a,b   Chen, Si Yuan ^a,b   Feng, Li Hong ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA REHABILITATION RESEARCH CENTER   (China)

Author keywords

Atherogenesis; Chemokine; Cytokine; Hyperlipidemia; Leukocyte

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINE CXCL12; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERLIPIDEMIAS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LEUKOCYTOSIS; MALE; MIDDLE AGED; RECEPTORS, CXCR4; SEX FACTORS; STROMAL CELLS;

EID: 84870815601     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.228.355     Document Type: Article

References (27)

1. Abi-Younes, S., Sauty, A., Mach, F., Sukhova, G.K., Libby, P. & Luster, A.D. (2000) The stromal cell-derived factor-1 chemo- kine is a potent platelet agonist highly expressed in atheroscle-rotic plaques. Circ. Res., 86, 131-138.
2. Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A., Thelen, M., Montes, M., Virelizier, J.L., Delepierre, M., Baleux, F., Lortat-Jacob, H. & Arenzana-Seisdedos, F. (1999) Stromal cell- derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem., 274, 23916-23925.
3. Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med., 184, 1101-1109.
4. Bobryshev, Y.V. (2006) Monocyte recruitment and foam cell formation in atherosclerosis. Micron., 37, 208-222.
5. Chen, J.Q., Liu, W.L., Zhang, C.X., Wang, M.C. & Li, L. (2011) TLR4 signaling pathway involved in repairing of vascular infammation damaged by aerobic exercise on ApoE knockout in mice. Chi. Sport. Sci., 31, 53-58.
6. Damås, J.K., Waehre, T., Yndestad, A., Ueland, T., Müller, F., Eiken, H.G., Holm, A.M., Halvorsen, B., Frøland, S.S., Gullestad, L. & Aukrust, P. (2002) Stromal cell-derived factor-1 alpha in unstable angina: potential anti-infammatory and matrix-stabilizing effects. Circulation, 106, 36-42.
7. De La Luz Sierra, M., Yang, F., Narazaki, M., Salvucci, O., Davis, D., Yarchoan, R., Zhang, H.H., Fales, H. & Tosato, G. (2004) Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood, 103, 2452-2459.
8. Fedyk, E.R., Jones, D., Critchley, H.O., Phipps, R.P., Blieden, T.M. & Springer, T.A. (2001) Expression of stromal-derived factor-1 is decreased by IL-1 and TNF in dermal wound healing. J. Immunol., 166, 5749-5754.
9. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estima- tion of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502.
10. Gomes, A.L., Carvalho, T., Serpa, J., Torre, C. & Dias, S. (2010) Hypercholesterolemia promotes bone marrow cell mobiliza- tion by perturbing the SDF-1: CXCR4 axis. Blood, 115, 3886-3894.
11. Gupta, S.K., Lysko, P.G., Pillarisetti, K., Ohlstein, E. & Stadel, J.M. (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regu- lation by infammatory cytokines. J. Biol. Chem., 273, 4282-4287.
12. Han, K.H., Han, K.O., Green, S.R. & Quehenberger, O. (1999) Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differen- tial effects of plasma lipoproteins on monocyte function. J. Lipid Res., 40, 1053-1063.
13. Han, Y., Wang, J., He, T. & Ransohoff, R.M. (2001) TNF-alpha down-regulates CXCR4 expression in primary murine astro- cytes. Brain Res., 888, 1-10.
14. Hestdal, K., Aukrust, P., Müller, F., Lien, E., Bjerkeli, V., Espevik, T. & Frøland, S.S. (1997) Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor recep- tors on mononuclear cells in human immunodefciency virus type 1: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. Blood, 90, 2670-2679.
15. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. (2007) Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhong hua Xin Xue Guan Bing Za Zhi., 35, 390-419.
16. Jung, C., Fischer, N., Fritzenwanger, M., Pernow, J., Brehm, B.R. & Figulla, H.R. (2009) Association of waist circumference, traditional cardiovascular risk factors, and stromal-derived factor-1 in adolescents. Pediatr. Diabetes, 10, 329-335.
17. Nordøy, I., Müller, F., Nordal, K.P., Rollag, H., Lien, E., Aukrust, P. & Froland, S.S. (2000) The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J. Infect. Dis., 181, 51-57.
18. Poznansky, M.C., Olszak, I.T., Foxall, R., Evans, R.H., Luster, A.D. & Scadden, D.T. (2000) Active movement of T cells away from a chemokine. Nat. Med., 6, 543-548.
19. Ramsay, T.G. (1996) Fat cells. Endocrinol. Metab. Clin. North Am., 25, 847-870.
20. Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S. & Tosato, G. (2002) Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood, 99, 2703-2711.
21. Salvucci, O., Basik, M., Yao, L., Bianchi, R. & Tosato, G. (2004) Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J. Leukoc. Biol., 76, 217-226.
22. Steinberg, D. (2002) Atherogenesis in perspective: hypercholester- olemia and infammation as partners in crime. Nat. Med., 8, 1211-1217.
23. Stellos, K., Ruf, M., Sopova, K., Kilias, A., Rahmann, A., Stamatelopoulos, K., Jorbenadze, R., Geisler, T., Gawaz, M. & Bigalke, B. (2011) Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: effect of clin- ical presentation and cardiovascular risk factors. Atheroscle- rosis, 219, 913-916.
24. Tashiro, K., Tada, H., Heilker, R., Shirozu, M., Nakano, T. & Honjo, T. (1993) Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science, 261, 600-603.
25. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. & Hotamisligil, G.S. (1997) Protection from obesity induced insulin resistance in mice lacking TNF-alpha function. Nature, 389, 610-614.
26. Yao, L., Salvucci, O., Cardones, A.R., Hwang, S.T., Aoki, Y., De La Luz Sierra, M., Sajewicz, A., Pittaluga, S., Yarchoan, R. & Tosato, G. (2003) Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi's sarcoma pathogenesis. Blood, 102, 3900-3905.
27. Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K., Svenja Meiler, S., Regina Krohn, R., Schober, A., Sperandio, M., Oliver Soehnlein, O., Bornemann, J., Tacke, F., Biessen, E.A. & Weber, C. (2008) Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res., 102, 209-217.